[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Nakagawa et al., 1996 - Google Patents

Tacrolimus has antifungal activities against Malassezia furfur isolated from healthy adults and patients with atopic dermatitis

Nakagawa et al., 1996

Document ID
11190629511249925838
Author
Nakagawa H
Etoh T
Yokota Y
Ikeda F
Hatano K
Teratani N
Shimomura K
Mine Y
Amaya T
Publication year
Publication venue
Clinical drug investigation

External Links

Snippet

Summary Tacrolimus (FK506), a new immunosuppressant used clinically in the prevention of allograft rejection, has been shown to be effective when used topically in atopic dermatitis, especially for face and neck lesions. Because Malassezia furfur, normally found in the …
Continue reading at link.springer.com (other versions)

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/41641,3-Diazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin digitoxin or digoxin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Micro-organisms or materials therefrom
    • A61K35/74Bacteria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06Fungi, e.g. yeasts
    • A61K36/062Ascomycota
    • A61K36/064Saccharomycetales, e.g. baker's yeast
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/155Amidines (), e.g. guanidine (H2N-C(=NH)-NH2), isourea (N=C(OH)-NH2), isothiourea (-N=C(SH)-NH2)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K8/00Cosmetic or similar toilet preparations
    • A61K8/18Cosmetic or similar toilet preparations characterised by the composition
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILET PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILET PREPARATIONS
    • A61Q17/00Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings

Similar Documents

Publication Publication Date Title
Nakagawa et al. Tacrolimus has antifungal activities against Malassezia furfur isolated from healthy adults and patients with atopic dermatitis
Rodríguez-Cerdeira et al. Biofilms and vulvovaginal candidiasis
EP3471836B1 (en) Dermatological preparations for maintaining and/or restoring healthy skin microbiota
US20220273595A1 (en) Compositions and methods for treating eczema
EP2648742B1 (en) Formulations comprising saponins and uses thereof
WO2016114976A1 (en) Compositions and methods for inhibiting fungal infections
US20170071990A1 (en) Compositions containing boric acid and a mixture of lactobacillus
US20160228465A1 (en) Modified Saponins For the Treatment of Fungal Infections
DE112015004182T5 (en) An antifungal composition comprising antimycotic peptide and terpene alcohol
WO2025017520A1 (en) Selective antibacterial use of micrococcus luteus
Dubini et al. In vitro antimycotic activity and nail permeation models of a piroctone olamine (octopirox) containing transungual water soluble technology
de Sá et al. Antivirulence activity and in vivo efficacy of a thiazole derivative against candidiasis
EP3478302B1 (en) Preparation with the viable mycoparasitic microorganism pythium oligandrum for the treatment of dermaphytoses and yeast infections on the skin and mucous membranes
EP3244889B1 (en) Pharmaceutical composition for the treatment of mycosis
JP3849988B2 (en) Antifungal agent
EP4346864A1 (en) Method for the treatment of microbial overgrowth, imbalance and infections
KR102243333B1 (en) Antimicrobial peptide, Poecilocorisin 4 derived from Poecilocoris lewisi and uses thereof
KR102239880B1 (en) Antimicrobial peptide, Poecilocorisin 2 derived from Poecilocoris lewisi and uses thereof
Carrión Navarro et al. A New Natural Antimycotic Agent is Effective Against Oropharyngeal Candidiasis: The VIPROCAN Study
KR101597505B1 (en) Cosmetic composition for prevention or improvement of sensitive skin comprising mixture oil extracted of Euryale ferox, Euphorbia lathyris L. and Rosa multiflora fruit
KR102243339B1 (en) Antimicrobial peptide, Poecilocorisin 3 derived from Poecilocoris lewisi and uses thereof
US20240325358A1 (en) Pharmaceutical composition for prevention or treatment of allergic skin disease or skin pruritus
KR102243315B1 (en) Antimicrobial peptide, tenoderasin-2 derived from Tenodera sinensis and uses thereof
US8192750B2 (en) Pharmaceutical composition for the treatment of otomycosis
Moroianu et al. STUDY ON THE INTERNAL AND EXTERNAL FACTORS INVOLVED IN THE PATHOGENESIS OF DISEASES DETERMINED BY CANDIDA GENUS AND SPECIES